Searched for
REMDESIVIR INDIA PRICE
India's Remdesivir production capacity increased to 122.49 lakh vials per month in June: GovtShortages of Remdesivir injections in the market were noticed in April and May 2021 due to a sudden surge in the demand for the drug for ma...- How Indian pharma companies should have dealt with Remdesivir crisisIncidentally, pharma companies have been conspicuous by their silence, busy making hay while the sun shines. Except for disseminating helpl...
- Writ petition filed to issue CL for Covid drugs, regulate vaccine pricesNon-governmental organisation Jan Swasthya Abhiyan (JSA) filed a writ petition in the Supreme Court, seeking a direction to the Union gover...
- Amid high demand for Remdesivir, 3 lakh vials to be produced daily within two weeks: Mansukh MandaviyaUnion Chemical and Fertilizer Minister Mansukh Mandaviya told ANI that within two weeks, 3 lakh vials of Remdesivir will be supplied to the...
- Pharma companies cut remdesivir injection prices on govt intervention: NPPAMinister of State for Chemicals and Fertilisers Mansukh Mandaviya held meetings with drug manufacturers and other stakeholders on April 12 ...
- Maharashtra seeks compulsory licence for RemdesivirCompulsory licensing (CL) allows the central government to revoke a patent and give other manufacturers permission to produce a drug under ...
- Govt approves ramping up remdesivir production to around 78 lakh vials per monthThe current total installed capacity of the seven manufacturers of remdesivir is 38.80 lakh vials per month, the Ministry of Chemicals and ...
- Ramping production of Remdesivir to meet demand: Pharma firmsA Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing...
- Remdesivir sells at 10x prices, NPPA unable to regulate as it's not notified as a 'drug'The NPPA can only control prices of devices and products that are defined as drugs under the Drugs and Cosmetics Act. A product or device t...
- Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?The DoP has asked the health ministry and drug regulatory authority to monitor if hospitals are prescribing the high-priced remdesivir wher...
- Remdesivir makers told to ramp up production by the department of pharmaceuticalsDelhi’s state regulator has written to chemists' association also about illegal imports of Covid-related drugs remdesivir, favipiravir and ...
- Cipla rises 2% as drugmaker launches remdesivir generic at Rs 4,000 per vialPharmaceutical major Mylan NV said its generic version of remdesivir will be priced at Rs 4,800
- Cipla launches generic version of remdesivir at Rs 4,000 per vial"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials ...
- Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vialThe DCGI has approved the company's remdesivir 100 mg per vial for restricted emergency use in India as part of the regulator's accelerated...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patientGilead has tied up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesi...
- Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across IndiaThe company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to ...
- Cipla to price remdesivir version for COVID-19 under 5,000 rupeesIndian pharma major Cipla Ltd and Hetero Labs gained approval to sell generic versions of remdesivir in the country. Remdesivir, intravenou...
- Indian licensees free to price Remdesivir: GileadUS drug maker to launch own brand of Covid-19 experimental drug in the country next month. Gilead has licensed the drug to four companies —...
- Will Gilead’s Covid-19 drug lift sustain for Jubilant Life, Cipla?Use of remdesivir is said to reduce hospital stay by 31 per cent to 11 days from 15 days.
Load More
